Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilysys, Inc. stock logo
AGYS
Agilysys
$79.21
-4.5%
$80.58
$62.00
$91.61
$2.17B0.68197,774 shs123,976 shs
IonQ, Inc. stock logo
IONQ
IonQ
$8.94
-0.7%
$9.22
$5.38
$21.60
$1.86B2.176.55 million shs3.90 million shs
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
$23.94
$23.89
$15.23
$23.98
$1.61B0.77659,586 shsN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$46.70
0.0%
$44.03
$32.69
$52.69
$933.53M0.68107,990 shs57,840 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilysys, Inc. stock logo
AGYS
Agilysys
-4.49%-4.57%-3.50%-4.03%+2.80%
IonQ, Inc. stock logo
IONQ
IonQ
-0.67%-0.28%-3.97%-12.95%+65.25%
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.00%0.00%0.00%0.00%+42.93%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-0.04%+4.50%+21.42%+23.35%+14.74%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilysys, Inc. stock logo
AGYS
Agilysys
2.5403 of 5 stars
2.53.00.00.01.35.01.3
IonQ, Inc. stock logo
IONQ
IonQ
1.1278 of 5 stars
3.31.00.00.02.02.50.0
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.2268 of 5 stars
1.00.00.00.00.61.71.9
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
2.0475 of 5 stars
2.51.00.80.01.94.21.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilysys, Inc. stock logo
AGYS
Agilysys
3.00
Buy$88.7512.04% Upside
IonQ, Inc. stock logo
IONQ
IonQ
2.50
Moderate Buy$16.5084.56% Upside
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
2.00
Hold$21.98-8.17% Downside
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
3.00
Buy$53.0013.49% Upside

Current Analyst Ratings

Latest SLP, AGYS, IONQ, and NXGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/29/2024
IonQ, Inc. stock logo
IONQ
IonQ
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$13.00 ➝ $11.50
2/29/2024
IonQ, Inc. stock logo
IONQ
IonQ
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$18.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilysys, Inc. stock logo
AGYS
Agilysys
$198.07M10.94$1.16 per share68.43$4.34 per share18.25
IonQ, Inc. stock logo
IONQ
IonQ
$22.04M84.46N/AN/A$2.35 per share3.80
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
$653.17M2.46$1.16 per share20.57$6.31 per share3.79
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$59.58M15.67$0.84 per share55.92$8.86 per share5.27

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilysys, Inc. stock logo
AGYS
Agilysys
$14.58M$3.1924.83144.02N/A38.27%20.54%10.64%5/13/2024 (Confirmed)
IonQ, Inc. stock logo
IONQ
IonQ
-$157.77M-$0.78N/AN/AN/A-715.77%-28.27%-25.48%5/8/2024 (Confirmed)
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
-$2.65M-$0.10N/A27.52N/A-0.89%11.37%5.38%N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$9.96M$0.5388.11N/A16.22%7.95%7.35%7/4/2024 (Estimated)

Latest SLP, AGYS, IONQ, and NXGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2024N/A
Agilysys, Inc. stock logo
AGYS
Agilysys
$0.24N/A-$0.24N/AN/AN/A  
5/8/2024N/A
IonQ, Inc. stock logo
IONQ
IonQ
-$0.26N/A+$0.26N/AN/AN/A  
4/3/2024Q2 2024
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.18$0.20+$0.02$0.20$17.31 million$18.31 million      
2/28/2024Q4 2023
IonQ, Inc. stock logo
IONQ
IonQ
-$0.23-$0.20+$0.03-$0.20$5.70 million$6.11 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilysys, Inc. stock logo
AGYS
Agilysys
N/AN/AN/AN/AN/A
IonQ, Inc. stock logo
IONQ
IonQ
N/AN/AN/AN/AN/A
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
N/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.240.51%N/A45.28%N/A

Latest SLP, AGYS, IONQ, and NXGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/3/2024
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Quarterly$0.060.5%4/26/20244/29/20245/6/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilysys, Inc. stock logo
AGYS
Agilysys
N/A
2.01
1.94
IonQ, Inc. stock logo
IONQ
IonQ
N/A
10.49
10.49
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.63
2.52
2.52
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
8.81
8.81

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Agilysys, Inc. stock logo
AGYS
Agilysys
88.00%
IonQ, Inc. stock logo
IONQ
IonQ
41.42%
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
76.65%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%

Insider Ownership

CompanyInsider Ownership
Agilysys, Inc. stock logo
AGYS
Agilysys
23.60%
IonQ, Inc. stock logo
IONQ
IonQ
13.00%
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
4.60%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
20.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Agilysys, Inc. stock logo
AGYS
Agilysys
1,60027.36 million20.90 millionOptionable
IonQ, Inc. stock logo
IONQ
IonQ
324208.23 million181.16 millionOptionable
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
2,78367.10 million64.01 millionOptionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19219.99 million15.81 millionOptionable

SLP, AGYS, IONQ, and NXGN Headlines

SourceHeadline
Walter S. Woltosz Sells 20,000 Shares of Simulations Plus, Inc. (NASDAQ:SLP) StockWalter S. Woltosz Sells 20,000 Shares of Simulations Plus, Inc. (NASDAQ:SLP) Stock
insidertrades.com - May 3 at 6:59 AM
Insider Sale at Simulations Plus Inc (SLP): Director and 10% Owner Walter Woltosz Sells 20,000 ...Insider Sale at Simulations Plus Inc (SLP): Director and 10% Owner Walter Woltosz Sells 20,000 ...
finance.yahoo.com - May 3 at 2:56 AM
Simulations Plus (NASDAQ:SLP) Shares Pass Above 200-Day Moving Average of $40.99Simulations Plus (NASDAQ:SLP) Shares Pass Above 200-Day Moving Average of $40.99
americanbankingnews.com - April 26 at 3:20 AM
Simulations Plus Inc.Simulations Plus Inc.
wsj.com - April 17 at 5:46 PM
Simulations Plus (NASDAQ:SLP): Promising Potential in Biotech SoftwareSimulations Plus (NASDAQ:SLP): Promising Potential in Biotech Software
msn.com - April 16 at 11:14 AM
SLP Sep 2024 55.000 callSLP Sep 2024 55.000 call
finance.yahoo.com - April 15 at 6:31 PM
New AI Bot Predicts These 7 Stocks Will Mint MillionairesNew AI Bot Predicts These 7 Stocks Will Mint Millionaires
investorplace.com - April 12 at 1:53 PM
Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Conestoga Capital Advisors LLCSimulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Conestoga Capital Advisors LLC
marketbeat.com - April 10 at 3:54 PM
Simulations Plus (NASDAQ:SLP) Stock Price Up 5.2%Simulations Plus (NASDAQ:SLP) Stock Price Up 5.2%
marketbeat.com - April 8 at 2:30 PM
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDASimulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
zacks.com - April 8 at 10:10 AM
Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call TranscriptSimulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript
seekingalpha.com - April 6 at 3:58 PM
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This YearEarnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
finance.yahoo.com - April 6 at 10:39 AM
Simulations Plus Second Quarter 2024 Earnings: Beats ExpectationsSimulations Plus Second Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - April 5 at 9:07 AM
Simulations Plus, Inc. to Issue Quarterly Dividend of $0.06 (NASDAQ:SLP)Simulations Plus, Inc. to Issue Quarterly Dividend of $0.06 (NASDAQ:SLP)
marketbeat.com - April 5 at 7:30 AM
Simulations Plus Shares Rise 27% Following FDAs License Renewal for Dilisym Software PlatformSimulations Plus Shares Rise 27% Following FDA's License Renewal for Dilisym Software Platform
marketwatch.com - April 4 at 11:06 PM
Simulations Plus (NASDAQ:SLP) Shares Gap Up  After Strong EarningsSimulations Plus (NASDAQ:SLP) Shares Gap Up After Strong Earnings
marketbeat.com - April 4 at 1:20 PM
Simulations Plus stock jumps 25% amid FDA renewal, earnings reportSimulations Plus stock jumps 25% amid FDA renewal, earnings report
msn.com - April 4 at 1:05 PM
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call TranscriptSimulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
finance.yahoo.com - April 4 at 1:05 PM
Simulations Plus (NASDAQ:SLP) Posts Quarterly  Earnings Results, Beats Expectations By $0.02 EPSSimulations Plus (NASDAQ:SLP) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
marketbeat.com - April 4 at 11:58 AM
U.S. FDA Renews DILIsym® Software Licenses for 7th YearU.S. FDA Renews DILIsym® Software Licenses for 7th Year
businesswire.com - April 4 at 8:30 AM
Q2 2024 Simulations Plus Inc Earnings CallQ2 2024 Simulations Plus Inc Earnings Call
finance.yahoo.com - April 4 at 8:04 AM
Simulations Plus (SLP) Q2 Earnings & Revenues Beat EstimatesSimulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates
zacks.com - April 4 at 7:36 AM
Simulations Plus, Inc. 2024 Q2 - Results - Earnings Call PresentationSimulations Plus, Inc. 2024 Q2 - Results - Earnings Call Presentation
seekingalpha.com - April 3 at 11:16 PM
SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024
investorplace.com - April 3 at 10:05 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Agilysys logo

Agilysys

NASDAQ:AGYS
Agilysys, Inc., together with its subsidiaries, operates as a developer and marketer of hardware and software products and services to the hospitality industry in North America, Europe, the Asia-Pacific, and India. It offers point of sale, property management systems, inventory and procurement, payments, activity scheduling, reservations management, and related solutions to enhance guest experience. The company also provides cloud applications, support, maintenance, and subscription services; and professional services. It offers its solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare applications. The company was formerly known as Pioneer-Standard Electronics, Inc. and changed its name to Agilysys, Inc. in 2003. Agilysys, Inc. was founded in 1932 and is headquartered in Alpharetta, Georgia.
IonQ logo

IonQ

NYSE:IONQ
IonQ, Inc. engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems. The company was founded in 2015 and is headquartered in College Park, Maryland.
NextGen Healthcare logo

NextGen Healthcare

NASDAQ:NXGN
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is based in Atlanta, Georgia.
Simulations Plus logo

Simulations Plus

NASDAQ:SLP
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.